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Abstract-The distributions of four prodynorphin-derived peptides, dynorphin A (l-171, 
dynorphin A (I-81, dynorphin B, and cr-neo-endorphin were determined in 10 cortical regions 
and the striatum of the old world monkey (Macaca nemestrina). a-neo-endorphin was the most 
abundant peptide in both cortex and striatum. The concentrations of all four peptides were 
significantly greater in the striatum compared to the cortex. In general, concentrations of each 
peptide tended to be higher in allocortex than in neocortex. Possible inter- and intradomain 
processing differences, as estimated by ratios of these peptides, did not vary within cortex, but 
the intradomain peptide ratio, dyn A (l-17)/dyn A (l-81, was significantly greater in cortex than 
in striatum. These results indicate that prodynorphin is, in some ways, uniquely processed in 
the primate. Particularly unusual is the relatively low abundance of prodynorphin-derived 
products in the cortex, in the face of moderately high levels of kappa opiate receptor expression. 
Introduction 
Prodynorphin, proenkephalin, and pro- 
opiomelanocortin are the 3 propeptides that serve 
as precursors to endogenous opioid peptides. These 
3 precursors make a number of peptide ligands 
with affinities at opiate receptors. Prodynorphin 
produces ligands with varying affinities for the p 
and 6 opiate receptors,’ but differs from pro- 
opiomelanocortin and proenkephalin by also pro- 
ducing peptides with affinity for the K opiate 
receptor.’ 3 domains have been identified in the 
prodynorphin molecule, the dynorphin A, leu- 
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morphin, and neoendorphin domains.’ Dynorphin 
A, which is dynorphin A (l-1 7) (dyn A (l-l 7)), can 
be further processed into dynorphin A (l-8) (dyn A 
(l-8)) (Fig. 1).14.17 Dyn A (l-1 7) has greater affinity 
for the K opiate receptor than dyn A (l-8).’ The 
leumorphin domain can be further processed into 
dynorphin B (dyn B).” Dyn B has an affinity for 
the K opiate receptor similar to dyn A (1-17).9 The 
neoendorphin domain, which is a-neo-endorphin 
(tx-neo) can be further processed into p-neo- 
endorphin (j?-neo).6. I3 a-neo has an affinity for the 
K opiate receptor similar to dyn B and dyn A (l- 
17).9 These 3 molecules also bind to p and 6 opiate 
receptors, but these affinities are 6 to 20 times less 
than their affinities for the K opiate receptor.’ The 
extent of how each domain is processed may thus 
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Fig. 1 Schematic representation of the prodynorphin molecule. There are 3 domains, the neoendorphin domain (a-neoendorphin 
(a-neo) potentially processed into /I-neoendorphin (/I-neo)), the dynorphin A (dyn A) domain (dyn A (1-17) potentially processed 
into dyn A (l-8)), and the Ieumorphin domain potentially processed into dynorphin B (dyn B)). 
alter the functional opioid selectivity of the 
domain.2 However, the physiological activity of 
prodyn is not only determined by expression and 
processing of these domains, but also by the specific 
anatomical locations of where the peptides (and 
associated opiate receptors) are expressed. 
Prodynorphin has been most extensively studied 
in the rodent. A specific pattern of distribution of 
prodynorphin-containing cells and fibers in rodent 
brain has been found using immunocytochemistry, 
with prod$norphin being visualized in the caudate- 
putamen, substantia nigra, hippocampus, hypo- 
thalamus, amygdala, parabrachial nucleus, nucleus 
tractus solitarius, substantia grisea centralis, as well 
as in much of the cortex.4,8*12,17.22 Kappa receptors 
have been visualized via receptor autoradiography, 
with their distribution being similar to that of the 
prodynorphin-containing fibers.1’*‘2 This would be 
expected, given that prodynorphin is the only 
known source of endogenous kappa ligands. Pro- 
dynorphin derived peptide concentrations have also 
been examined in dissected brain regions, using 
radioimmunoassay. In general, the distribution of 
immunoreactive prodynorphin derived peptides 
Table 1 Cortical regions studied 
Region Corresponding 





























secondary motor (premotor) 
secondary somatosensory (area 5) 
parallels the distribution of both prodynorphin 
fibers and IC receptor binding in rodent brain. 
Further, concentrations of various prodynorphin 
derived peptides appear to be similar in the rodent 
striatum and cortex.” In those regions in which 
fairly detailed examination of the various pro- 
dynorphin derived peptides have been performed 
(primarily rat striatum and cortex), several con- 
sistent observations have been made. In the rat 
brain, a-neo is, by far, the most abundant peptide 
present. The A and B domains are present in much 
lower concentrations, and the A domain is pref- 
erentially processed to dyn A ( l-8). 
The primate prodynorphin/kappa system has not 
been studied as extensively as in the rat. The dis- 
tribution of prodynorphin-containing cells and 
fibers is similar in the primate, although the density 
of these cells is greater in primate cortex than in 
rodent cortex.3.7.‘0 Interestingly, the density of 
kappa receptors in the cortex also seems to increase 
with phylogeny, with cortical kappa receptors being 
far more abundant in the primate than the 
rodent.“,” Detailed examination of the specific 
forms of prodynorphin-derived peptides expressed 
in primate brain, however, has not been performed. 
We undertook this study to begin to characterize 
the expression of specific forms of prodynorphin in 
selected brain regions of the primate. Given the 
relative abundance of prodynorphin fibers and 
cells, as well as IC receptors in the cortex of the 
primate compared to the rodent, we have con- 
centrated on the examination of the cortex, com- 
paring it to the striatum. We have therefore 
determined the concentrations of 4 prodynorphin- 
derived peptides, representing all three functional 
domains of the propeptide, in neocortical, allo- 
cortical, and striatal regions of the old-world mon- 
key brain. 
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Methods 
Animals 
The brains of 6 old world monkeys (Macaca neme- 
strina) were obtained from several sources. All 
monkeys were in good health and medication-free 
at the time of tissue acquisition. These monkeys 
were ail sacrificed for other studies, and the brains 
were rapidly removed and frozen at - 80°C for later 
study. 
Tissue preparation 
Frozen whole brains were removed from - 80” stor- 
age and kept on wet ice until sufficiently thawed to 
dissect (approximately - 20”). Brains were cut into 
5-l 0 mm slabs in a coronal plane. These slabs were 
conservatively dissected on wet ice into the specific 
regions of interest, using the atlas and nomenclature 
of Von Bonin and Bailey.” Dissected tissue was 
promptly frozen on dry ice and stored at -80°C 
until extracted for assay. The individual regions 
were weighed while frozen, and immediately homo- 
genized in GT buffer (10 mM EDTA, 50 mM Tris 
pH 7.5. and 5M guanidine thiocyanate) with a 
Brinkman Polytron. 6 volumes of 4M LiCl were 
added to each sample, and samples were placed on 
ice overnight. The samples were centrifuged for 30 
set at IO 000 rpm and the supernatant was trans- 
fered to a clean tube. Glacial acetic acid was added 
to a final volume of 5% and each sample was 
extracted using Sep-Pak C,, cartridges, as pre- 
viously described.” The eluant from the cartridges 
was dried with a Savant Speed Vat rotary evap- 
orator. The dried extract was resuspended in meth- 
anol:O. 1 N HCl (1: 1, v:v), and stored at -20°C 
until assayed. 
Radioimmunoassays 
Radioimmunoassays (RIAs) were performed as 
previously described.17.” Briefly, diluted tissue sam- 
ple or peptide standard, ‘251-labeled peptide (SOOO- 
10 000 cpm), and diluted antiserum were incubated 
in a total volume of 300 ~1 overnight at 4°C. The 
reaction was terminated by the addition of 0.6 ml 
of charcoal slurry, and the assay tube centrifuged 
for 10 min at 7500 x g. The pellet was discarded and 
the supernatant counted in a TM Analytic 1290 
gamma counter. All samples were assayed in trip- 
licate. Radiolabeled peptides for RIA were pre- 
pared by chloramine-T-mediated iodination.6 
Antisera were raised in rabbits, and were the gift of 
Dr Huda Akil (Mental Health Research Institute, 
University of Michigan). 
Data analysis 
Peptide concentration values from 3 independent 
assays were averaged, and used for subsequent data 
analysis. Prodynorphin can be processed into three 
domains2 (Fig. 1). To estimate potential variations 
of interdomain processing, the ratios of a-neo/[dyn 
A (l-l 7) + dyn A (l-8) (hereafter, total dyn A)] and 
dyn B/total dyn A were calculated. These ratios 
would be expected to be unity if prodynorphin was 
processed into equimolar amounts of the three 
domains, though because /I-neo and leumorphin 
were not assayed, these ratios might be somewhat 
less than unity. To estimate possible processing 
differences within one prodynorphin domain, the 
ratio dyn A (l-l 7)/dyn A (l-8) was calculated. The 
dyn A region was chosen because dyn A (l-l 7) and 
dyn A (1-8) have different affinities for the opiate 
receptors, and processing differenees may thus be 
important physiologically. Potential regional 
differences were determined by analysis of variance, 
with post-hoc Dunnett’s t-test. 
Results 
Peptide content 
The concentrations of the 4 prodynorphin derived 
peptides were determined in the caudate, putamen, 
and 10 selected cortical regions, as shown in Figure 
2 and Table 2. For each peptide, the concentrations 
in the caudate and putamen were quite similar, 
although a-neo tended to be more abundant in the 
putamen than in the caudate. a-neo was the most 
abundant of the 4 peptides in both striatal regions, 
which was 5-8 times the concentration of dyn B. 
The concentration of dyn A (l-8) was double that 
of the concentration of dyn A (1-17). The total dyn 
A concentrations were comparable to the con- 
centration of dyn B for both striatal regions. 
All 4 peptides were also found in the cortex, but 
at considerably lower concentrations (Fig. 2 and 
Table 2). There were no significant differences in the 
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Fig. 2 Peptide concentrations in 10 cortical regions of the old world monkey, expressed as means (+ SEM) in fmoles/mg of wet 
tissue. There were no significant regional differences, except for dyn B, in which allocortex levels were higher than neocortical 
concentrations, a trend seen for the other three peptides as well. For abbreviations, see Table 1. 
cortical regions (dyn A (l-l 7) F = 1.64; dyn A peptides, though reaching significance only for dyn 
(l-8) F = 1.78; a-neo F = 1.45; for all, df = 9, 50, B. 
p = N.S.) except dyn B (F = 8.25, df = 9, 50, Mean values for concentrations of each peptide 
p < 0.0001) (Fig. 2). The significance across cortical in cortex are summarized in Table 2. Because of the 
regions seen for dyn B concentration was pre- significant increase of dyn B and a trend toward an 
dominantly due to higher levels in the temporal increase of other peptides in allocortex, the cortical 
allocortex, a trend also seen for the other three regions have been separated into neocortex and 
Table 2 Comparison of expression of prodynorphin-derived peptides in striatum and cortex 
Neocortex Allocortrx 
Peptide Caudate Putamen Neocortex Allocortex caudate caudate 
dyn A (1-17) 21.80+5.50 24.00* 16.28 1.84+0.18 3.00+0.58 0.08 0.14 
dyn A (1-8) 49.33k10.11 51.91*20.79 1.56+0.18 3.02kO.63 0.03 0.06 
dyn B 75.11k5.52 75.81+27.62 3.65*0.28 12.88f2.63 0.05 0.17 
a-neo 397.87k45.84 597.61 k60.79 76.89k9.41 157.08 & 36.54 0.19 0.39 
Values are means + SEM, expressed as fmoles/mg of tissue. Putamen values represent the averages of 3 animals, while the values 
for the other structures are the averages of 6 animals. 
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Fig. 3 Interdomain processing in 10 cortical regions, as estimated by ratios of the 3 domains of prodynorphin, expressed as ratios 
kSEM. There were no significant regional differences in the interdomain processing ratios. 
allocortex in this table. As also seen in Figure 2, 
levels of each peptide were 2-3.5 times higher in 
allocortex than in neocortex. Like the striatal 
regions, cr-neo was the most abundant peptide in 
the cortex, followed by dyn B. The peptides derived 
from the dyn A region were least abundant. 
Interdomain processing 
To estimate the extent of interdomain processing in 
the striatum and cortical regions, the ratios of total 
dyn A/dyn B. a-neo/total dyn A, and cc-neo/dyn B 
were calculated. The ratio of total dyn A/dyn B was 
similar in the caudate and the putamen. The other 
2 ratios in the putamen were twice those seen in the 
caudate, which was accounted for by the higher 
concentration of a-neo in the putamen compared 
to the caudate. The cortical ratios of a-neo/total 
dyn A and a-neoldyn B tended to be higher than 
those in the striatum (cc-neo/total dyn A (F = 1.6 1, 
df = 11, 57, p = N.S.) and cl-neo/dyn B (F = 1.38, 
df = 11,57, p = N.S.). The total dyn A/dyn B ratio 
was approximately unity in the striatum and in the 
cortex (F = 1.26, df = 11, 57, p = N.S.) (Table 3). 
There were no significant regional differences in the 
3 ratios found in cortex (Fig. 2). 
In Table 3, the mean ratios have again been sep- 
arated into neocortex and allocortex. All 3 ratios 
tended to be greater in the neocortex than in the 
allocortex, especially total dyn A/Dyn B. For the 
total dyn AjDyn B ratio, the values in the neocortex 
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Fig. 4 Intradomain processing in the cortex, estimated as the 
ratio of dyn A(l-17)/dyn A(l-8). This ratio was significantly 
lower in the caudate and putamen compared to the cortex, 
though there were no significant differences between cortical 
regions. 
are similar to those in the striatum, while the allo- 
cortex ratio is approximately half of the neocortical 
and striatal ratios. For the 2 ol-neo ratios, the neo- 
cortical values tended to be greater than the allo- 
cortical values and both tended to be greater than 
the corresponding striatal values. 
Intradomain processing 
To estimate intradomain processing of the dyn A 
domain in striatal and cortical regions, the ratio of 
dyn A (l-l 7)/dyn A (l-8) was calculated (Table 3). 
The dyn A (I-17)/dyn A (l-8) ratio was similar in 
the caudate and the putamen, but was significantly 
less than in the cortex (F = 2.33, df = 11, 55, 
p < 0.05), with cortical values 2-3 times greater 
than striatal values. There were no significant 
differences within cortical regions (F = 1.35, 
df = 9,48, p = N.S.). When the neocortex and the 
allocortex were assessed separately, the neocortex 
tended to be about 1.5 times greater than the allo- 
cortex. Cortical regions appear to have higher con- 
centrations of dyn A (1-l 7), relative to dyn A ( I 
8), than does the striatum. 
Discussion 
Prodynorphin derived peptides have not been as 
extensively studied in primate brain as in rodent 
brain. While prodynorphin fibers and cells have 
been visualized in the primate brain, and are rela- 
tively abundant in the primate cortex and striatum, 
little is known concerning the expression of specific 
forms of prodynorphin derived peptides. This study 
has further characterized the prodynorphin system 
in the primate, by determining concentrations of 
prodynorphin derived peptides in the cortex and 
the striatum. Prodynorphin derived peptides were 
identified in all regions surveyed, but the con- 
centrations in striatum were appreciably greater 
than those found in various cortical regions. 
Further, prodynorphin appears to be differentially 
processed in the striatum and cortex, especially in 
how the dyn A domain is handled. 
As seen in previous reports concerning rodent 
cortex and striatum, the general pattern of 
expression of prodynorphin derived peptides in pri- 
mate brain was c+neo > dyn B 3 total dyn A. 
Given that we did not assay leumorphin or /?-neo, 
the predominance of a-neo may be even more pro- 
nounced than we found. One hypothesis to explain 
this relative abundance of cc-neo, first suggested for 
the rodent prodynorphin system,20 is that there are 
differential rates of processing of the 3 domains. 
Leu-enkephalin is the theoretical end product of 
the processing of all 3 domains. The cleavage site 
for dyn A (l-8) and dyn B to be further processed 
into leu-enkephalin is composed of arginine-argi- 
Table 3 Comparison of processing ratios of prodynorphin-derived peptides in striatum and cortex 
Neocortex Allocortex 
Ratio Caudate Putamen Neocorfex Allocortex caudate caudate 
dyn A (l-17)/ 0.43 f 0.05 0.37kO.12 1.47+0.13 1.05*0.10 3.42 2.44 
dyn A (l-8) 
dyn A/dyn B 0.9320.16 0.92kO.12 0.95 50.06 0.49*0.04 1.02 0.53 
a-neo/dyn A 6.3OkO.94 12.41 k4.71 29.06k4.19 27.60k5.29 4.61 4.38 
a-neo/dyn B 5.25 kO.38 10.29k3.30 23.23 f 2.77 13.46k2.92 4.42 2.56 
Putamen values (ratios+ SEM) represent the averages of 3 animals, while values for the other structures are the averages of 6 
animals. 
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nine residues, while the /I-neo cleavage site for sub- 
sequent processing is arginine-lysine. As has been 
previously suggested,” the arginine-lysine site in the 
neoendorphin domain may be less favorable for 
cleavage than the arginine-arginine sites in the other 
2 domains, and thus cleavage to leu-enkephalin may 
be favored in the dyn A and leumorphin domains. 
The end result of this would be less processing and 
the relative accumulation of the neoendorphin 
domain. 
Unlike the rodent, however, the striatum of the 
primate had greater concentrations of all 4 peptides 
than the cortex. This is similar to an earlier report 
restricted to concentrations of dyn B in primate 
brain.16 This is interesting, and perhaps unexpected, 
considering u receptor binding has been reported 
to be greater in the cortex than in the striatum.‘0,16.‘9 
One may well expect an increase in the number of 
binding sites to be associated with a parallel 
increase in the concentration of ligand for that 
receptor, which was not observed. This could 
potentially be explainable with higher rates of turn- 
over of the endogenous K ligands in the primate 
versus the rodent, or even the existence of other 
endogenous high-affinity K ligands. A more likely 
possibility is that cortical prodyn may be processed 
differently in the primate, with a shift toward pep- 
tides with relatively higher K affinities. 
While there appeared to be no heterogeneity 
between most regions of the primate cortex, the 
allocortical regions tended to have higher con- 
centrations of the 4 prodynorphin peptides than the 
neocortical regions, with dyn B reaching signifi- 
cance. This is similar to what is observed in the 
rodent cortex,” and may suggest a greater role of 
prodynorphin in allocortical function that is evol- 
utionarily preserved. 
Several differences of peptide processing, esti- 
mated by inter- or intradomain processing ratios, 
were observed in the primate, compared to similar 
indices in the rodent. The cc-neo/dyn B and cc-neo/ 
total dyn A interdomain ratios tended to be 3-4 
times greater in primate cortex compared to stri- 
atum. While these values are somewhat similar to 
those observed in the rodent, these ratios are not 
different between rodent striatum and cortex.” 
Given that cc-neo is the most abundant form in all 
studied regions of primate, the relative increase in 
u-neo in primate cortex suggests that this domain 
contributes more to the rc tone of the cortex than 
the striatum in the primate. The leumorphin and 
dyn A domains may be processed into leu-enke- 
phalin at a greater rate, in primate and rodent, 
but the greater processing difference in the primate 
cortex may mean that prodynorphin is also a sig- 
nificant source of 6 tone in the cortex. The total 
dyn A/dyn B ratio is approximately unity in the 
primate cortex and striatum, while the ratio in the 
rodent has been reported to be 24.“*” As leu- 
morphin was not assayed, this ratio in primate may 
even be less than unity. This suggests that the dyn 
A domain may be handled differently in the primate 
compared to the rodent, and processed to Ieu-enke- 
phalin preferentially over the leumorphin and neo- 
endorphin domains. 
Intradomain processing of the dyn A domain, 
estimated by the ratio of dyn A (I-17)/dyn A (I- 
8), also reflected some interesting relationships. The 
primate striatum ratio value was similar to those 
reported in the rodent striatum and cortex, all being 
0.2&0.43.‘7~20 However, the primate neo- and allo- 
cortical ratios were greater than unity. Even though 
the absolute content ofdyn A is lower in the primate 
cortex than the striatum, the greater K affinity of 
dyn A (l-l 7) may imply that the increase in K 
binding in primate cortex is related to this shift in 
the dyn A domain. 
Prodynorphin is expressed and processed differ- 
ently in the primate brain compared to the rodent, 
and is expressed differently within discrete systems 
of the primate brain. Brain prodynorphin pro- 
cessing is thus apparently not uniform across neural 
systems, nor across different species. The com- 
plexity of prodynorphin expression and processing, 
and its unique opiate receptor profile, needs to be 
the subject of future research to clarify its role in 
motor and higher cortical functions. 
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